Cargando…

Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

Epidermal growth factor inhibitors (EGFRI), the first targeted cancer therapy, are currently an essential treatment for many advance-stage epithelial cancers. These agents have the superior ability to target cancers cells and better safety profile compared to conventional chemotherapies. However, cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chanprapaph, K., Vachiramon, V., Rattanakaemakorn, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958662/ https://www.ncbi.nlm.nih.gov/pubmed/24723942 http://dx.doi.org/10.1155/2014/734249

Ejemplares similares

The incidence and management of cutaneous adverse events of the epidermal growth factor receptor inhibitors
por: Owczarek, Witold, et al.
Publicado: (2017)

Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors
por: Lupu, I, et al.
Publicado: (2015)

Cutaneous Mycobacterium abscessus Infection Associated with Mesotherapy Injection
por: Wongkitisophon, Pranee, et al.
Publicado: (2011)

Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review
por: Chirasuthat, Phatcharawat, et al.
Publicado: (2020)

Outcome of Repeated Use of Donor Site for Noncultured Epidermal Cellular Grafting in Stable Vitiligo: A Retrospective Study
por: Vachiramon, Vasanop, et al.
Publicado: (2019)

Cutaneous and Extracutaneous Manifestations of Behçet’s Disease Linked to Its Disease Activity and Prognosis
por: Limtong, Preeyachat, et al.
Publicado: (2020)

Cutaneous Toxicity in Oncologic Patients Receiving Epidermal Growth Factor Receptor Inhibitors
por: POPA, CRISTINA-MARIA, et al.
Publicado: (2021)

Clinical Profile of Cutaneous Adverse Effects of Epidermal Growth Factor Receptor Inhibitors: A Prospective Observational Study of 76 Cases
por: Saraswat, Neerja, et al.
Publicado: (2019)

Adverse event profiles of epidermal growth factor receptor‐tyrosine kinase inhibitors in cancer patients: A systematic review and meta‐analysis
por: Yin, Xiaonan, et al.
Publicado: (2021)

Five-Year Retrospective Review of Acute Generalized Exanthematous Pustulosis
por: Thienvibul, Chitprapassorn, et al.
Publicado: (2015)

Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
por: Huang, Jing, et al.
Publicado: (2020)

The immunoexpression of epidermal growth factor receptor in cutaneous squamous cell carcinoma
por: Nichita, Mirela Marcela, et al.
Publicado: (2021)

Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
por: Rattanakaemakorn, Ploysyne, et al.
Publicado: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
por: Apalla, Zoe, et al.
Publicado: (2021)

Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
por: Bangsgaard, Nannie, et al.
Publicado: (2012)

Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes
por: Maka, Vinayak V., et al.
Publicado: (2014)

Eccrine Poroma Arising within Nevus Sebaceous
por: Girdwichai, Natnicha, et al.
Publicado: (2016)

Actinic Granuloma with Focal Segmental Glomerulosclerosis
por: Phasukthaworn, Ruedee, et al.
Publicado: (2016)

Unsuccessful Treatment of Cheilitis Granulomatosa with Oral Methotrexate
por: Sutharaphan, Thanapon, et al.
Publicado: (2019)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas
por: Veloso, Emerson Soares, et al.
Publicado: (2020)

Dermal Pathology in Melasma: An Update Review
por: Phansuk, Kachanat, et al.
Publicado: (2022)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines
por: Lacouture, Mario E., et al.
Publicado: (2020)

Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
por: Chen, Chieh-Hsun, et al.
Publicado: (2022)

Management of immune-related cutaneous adverse events with dupilumab
por: Kuo, Alyce Mei-Shiuan, et al.
Publicado: (2023)

The Use of Epidermal Growth Factor Receptor Type 2-Targeting Tyrosine Kinase Inhibitors in the Management of Epidermal Growth Factor Receptor Type 2-Positive Gastric Cancer: A Narrative Review
por: AlMazmomy, Asim M, et al.
Publicado: (2019)

Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review
por: Leporini, Christian, et al.
Publicado: (2013)

Pityriasis Lichenoides Et Varioliformis Acuta and Lymphomatoid Papulosis Type F: A Case Report of Two Entities in One Patient
por: Pomsoong, Cherrin, et al.
Publicado: (2022)

Fractional Carbon Dioxide Laser for Keratosis Pilaris: A Single-Blind, Randomized, Comparative Study
por: Vachiramon, Vasanop, et al.
Publicado: (2016)

Prevalence of Thyroid Abnormalities in Thai Patients with Vitiligo
por: Vachiramon, Vasanop, et al.
Publicado: (2017)

Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria
por: Chanprapaph, Kumutnart, et al.
Publicado: (2018)

Prevalence and Clinical Characteristics of Itch in Vitiligo and Its Clinical Significance
por: Vachiramon, Vasanop, et al.
Publicado: (2017)

Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis
por: Yang, Jingxuan, et al.
Publicado: (2010)

The Epidermal Growth Factor Receptor Increases Cytokine Production and Cutaneous Inflammation in Response to Ultraviolet Irradiation
por: El-Abaseri, Taghrid Bahig, et al.
Publicado: (2013)

Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis
por: Moldan, Matthew M., et al.
Publicado: (2013)

Heart Failure Associated With the Epidermal Growth Factor Receptor Inhibitor Osimertinib
por: Piper-Vallillo, Andrew J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41f0tn3769pr5bagdkd9o7k7ju